Daiichi Sankyo SWOT Analysis, Competitors & USP

Daiichi Sankyo

Parent Company

Daiichi Sankyo

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Passion for innovation, Compassion for patients

USP

It is one of the largest pharmaceutical company in Japan

Daiichi Sankyo STP

Segment

Oncology & Cardiovascular diseases

Target Group

Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease

Positioning

They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time

Daiichi Sankyo SWOT Analysis

Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Daiichi Sankyo :

1. Has a strong workforce of over 30,000 employees

2. Leading producer of Benicar which is angiotensin II receptor antagonist

3. It is one of the largest pharmaceutical company in Japan

4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others
5. Strong brand establishment through many major acquisitions

Weaknesses

1. Despite being a strong brand, had a limited market share due to international competitors

2. Operates in limited segments such as Oncology & Cardiovascular segment

Opportunities

1. Increasing world population and more awareness about health

2. More people suffering from chronic diseases such as cancer, cardiovascular diseases

3. Increasing awareness of healthcare solutions

Threats

1. Natural disasters in Japan

2. increasing stringency in drug development guidelines

3. Global economic slowdown

Daiichi Sankyo Competition

Competitors

Below are the 4 main Daiichi Sankyo competitors :

1. Takeda Pharmaceuticals
2. Teva pharmaceuticals

3. Astellas pharmaceuticals

4. AstraZeneca